Aristo Pharma Nordic ApS: Financial statements 2022
CVR: 32328768
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Aristo Pharma Nordic ApS (CVR 32328768) has filed annual accounts for 2022. In 2022, the company reported a gross profit of EUR 717,126 and a net result of EUR 51,525 compared with EUR 45,333 the year before. That is a decrease of 9.2% compared with the year before. Equity in the 2022 report amounted to EUR 112,247. The solvency ratio was 8.2%. The company had 5 employees in the financial year.
- Gross Profit
- EUR 717,126
- Profit/Loss
- EUR 51,525
- Equity
- EUR 112,247
- Total Assets
- EUR 1,376,068
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 717K EUR | 52K EUR | 112K EUR | 5 |
| 2021 | - | 789K EUR | 45K EUR | 61K EUR | 7 |
| 2020 | - | 805K EUR | 62K EUR | -1.3M EUR | 7 |
| 2019 | - | 470K EUR | -286K EUR | -1.3M EUR | 6 |
| 2018 | - | -949K EUR | -1.9M EUR | -3M EUR | 8 |
Official annual report
Keep an eye on Aristo Pharma Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 31, 2022, Sascha Rauschke is registered as director of Aristo Pharma Nordic ApS.
As of December 31, 2022, Kenneth Pedersen has stepped down as director of Aristo Pharma Nordic ApS.
Aristo Pharma Nordic ApS has published its annual report for 2021. Gross profit came to DKK 789,373, and the net result was DKK 45,333.
About Aristo Pharma Nordic ApS
Aristo Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2011. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named AMNEAL NORDIC ApS and COPHARMA ApS. The management consists of John Hudson Kriwet. The board consists of John Hudson Kriwet (chair), Jannes Paul Beeskow and Robert Maciej Szymanski. The company is owned by Aristo Pharma GmbH. The company has 1 employee (2026). In 2025, the company reported revenue of EUR 453,392 and a net result of EUR 21,589 compared with EUR 25,190 the year before. Equity in the 2025 report amounted to EUR 184,874.